Broyhill
Our archive holds 3 letters from Broyhill, behind 7 investment theses. Every quote below is copied verbatim from the letter it came from.
Broyhill’s own letters pageTheses · 7
- March 2026
Ball Corporation is a pure-play packaging company with capital return potential after its aerospace divestiture.
Read the full thesis - March 2026
IQVIA is a clinical research organization with sticky pharma demand, proprietary data, and valuation support despite AI concerns.
Read the full thesis - March 2026
Sotera Health is a mission-critical sterilization business with a duopoly position and valuation support despite litigation overhangs.
Read the full thesis - March 2026
Masco is a housing-related company whose normalized earnings power has improved through market share gains and expense efficiencies.
Read the full thesis - December 2025
Reckitt Benckiser is a focused hygiene and health company trading at a discount with multiple catalysts and defensiveness.
Read the full thesis - December 2025
Watches of Switzerland is a leading Rolex retailer with a high-margin model and attractive valuation.
Read the full thesis - December 2025
Avantor is a strategic life-sciences supplier with self-help levers amid an industry upturn despite execution issues.
Read the full thesis
Letter archive · 3
Funds · 2
- Broyhill AM2
- Broyhill Asset Management1
Get Broyhill’s next letter the day it lands
We track Broyhill alongside hundreds of other managers, read every letter, and pull out what they bought and sold. Warren AI reads the whole archive for you.
View plans→